Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan C Gea-Banacloche

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Seminars in Hematology|March 31, 2010
Rituximab-associated infectionsJuan C Gea-Banacloche
ACP Journal Club|March 17, 2006
Antibacterial prophylaxis reduced the incidence of fever in patients receiving chemotherapy for solid tumors or lymphomaJuan C Gea-Banacloche
Blood|July 2, 2013
Antiviral cell therapy: is this the future?Juan C Gea-Banacloche
Seminars in Hematology|April 20, 2023
Infectious complications of chimeric antigen receptor (CAR) T-cell therapiesJuan C Gea-Banacloche
Cancer Treatment and Research|September 26, 2009
Improvements in the prevention and management of infectious complications after hematopoietic stem cell transplantationJuan C Gea-Banacloche, James C Wade
Current Hematologic Malignancy Reports|January 7, 2014
Clostridium difficile: deleterious impact on hematopoietic stem cell transplantationAlejandro Callejas-Díaz, Juan C Gea-Banacloche
The Pediatric Infectious Disease Journal|November 7, 2007
Monoclonal antibody therapeutics and risk for infectionJuan C Gea-Banacloche, Geoffrey A Weinberg
Diagnostic Microbiology and Infectious Disease|October 10, 2008
Sepsis caused by Elizabethkingia miricola successfully treated with tigecycline and levofloxacinO'Neil Green, Patrick Murray, Juan C Gea-Banacloche
Blood Reviews|March 25, 2018
Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infectionsTalal Hilal, Juan C Gea-Banacloche, Jose F Leis
Critical Care Medicine|November 16, 2004
Sepsis associated with immunosuppressive medications: an evidence-based reviewJuan C Gea-Banacloche, Steven M Opal, James Jorgensen, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Seminars in Hematology|March 31, 2010
Rituximab-associated infectionsJuan C Gea-Banacloche
ACP Journal Club|March 17, 2006
Antibacterial prophylaxis reduced the incidence of fever in patients receiving chemotherapy for solid tumors or lymphomaJuan C Gea-Banacloche
Blood|July 2, 2013
Antiviral cell therapy: is this the future?Juan C Gea-Banacloche
Seminars in Hematology|April 20, 2023
Infectious complications of chimeric antigen receptor (CAR) T-cell therapiesJuan C Gea-Banacloche
Cancer Treatment and Research|September 26, 2009
Improvements in the prevention and management of infectious complications after hematopoietic stem cell transplantationJuan C Gea-Banacloche, James C Wade
Current Hematologic Malignancy Reports|January 7, 2014
Clostridium difficile: deleterious impact on hematopoietic stem cell transplantationAlejandro Callejas-Díaz, Juan C Gea-Banacloche
The Pediatric Infectious Disease Journal|November 7, 2007
Monoclonal antibody therapeutics and risk for infectionJuan C Gea-Banacloche, Geoffrey A Weinberg
Diagnostic Microbiology and Infectious Disease|October 10, 2008
Sepsis caused by Elizabethkingia miricola successfully treated with tigecycline and levofloxacinO'Neil Green, Patrick Murray, Juan C Gea-Banacloche
Blood Reviews|March 25, 2018
Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infectionsTalal Hilal, Juan C Gea-Banacloche, Jose F Leis
Critical Care Medicine|November 16, 2004
Sepsis associated with immunosuppressive medications: an evidence-based reviewJuan C Gea-Banacloche, Steven M Opal, James Jorgensen, et al.
Pageof 3